Sign in

RECURSION PHARMACEUTICALS, INC.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total revenue 0.07 0.06 0.04 0.04 0.01 0.00 0.00
Cost of revenue 0.12 0.05 0.04 0.05 0.01 0.06 0.05
Gross profit -0.05 0.01 0.00 -0.01 0.01 0.00 -0.04
Total operating expenses + 0.60 0.49 0.35 0.24 0.19 0.09 0.06
Operating income -0.65 -0.48 -0.35 -0.25 -0.18 -0.08 -0.06
Non-operating income (net) 0.00 0.01 0.02 0.01 0.00 0.00 0.00
Income before tax -0.64 -0.46 -0.33 -0.24 -0.19 -0.09 -0.06
Income tax expense 0.00 0.00 0.00 0.00 -0.01 0.00 0.00
Net income -0.64 -0.46 -0.33 -0.24 -0.18 -0.09 -0.06
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total revenue 0.01 0.04 0.01 0.02 0.01 0.00 0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.01 0.03 0.03 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.00 0.03 0.03 0.02 0.02 0.02 0.01 0.01
Gross profit -0.01 0.01 -0.02 0.00 -0.01 -0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 -0.01
Total operating expenses + 0.12 0.12 0.15 0.18 0.18 0.18 0.11 0.11 0.10 0.10 0.10 0.08 0.07 0.06 0.06 0.06 0.05 0.07 0.05 0.04 0.03 0.03 0.02 0.02 0.02
Operating income -0.13 -0.11 -0.17 -0.18 -0.19 -0.18 -0.10 -0.10 -0.10 -0.10 -0.10 -0.08 -0.07 -0.06 -0.06 -0.07 -0.06 -0.06 -0.05 -0.04 -0.03 -0.03 -0.02 -0.02 -0.02
Non-operating income (net) 0.01 0.00 0.01 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.12 -0.11 -0.16 -0.17 -0.20 -0.18 -0.10 -0.10 -0.09 -0.10 -0.09 -0.08 -0.07 -0.06 -0.06 -0.07 -0.06 -0.06 -0.05 -0.04 -0.03 -0.03 -0.02 -0.02 -0.02
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.12 -0.11 -0.16 -0.17 -0.20 -0.18 -0.10 -0.10 -0.09 -0.09 -0.09 -0.08 -0.07 -0.06 -0.06 -0.07 -0.06 -0.06 -0.05 -0.04 -0.03 -0.03 -0.02 -0.02 -0.02
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Total cash and short-term investments + 0.74 0.59 0.39 0.55 0.52 0.26 0.07
Accounts receivable, net 0.02 0.05 0.00 0.00 0.01 0.00 0.00
Inventories 0.00 0.00 0.00 0.01 0.01
Other current assets 0.04 0.07 0.04 0.02 0.01 0.00 0.01
Total current assets 0.81 0.71 0.44 0.57 0.53 0.27 0.08
Total non-current assets + 0.66 0.73 0.22 0.13 0.08 0.03 0.03
Total assets 1.47 1.45 0.65 0.70 0.61 0.30 0.10
Total current liabilities + 0.15 0.19 0.09 0.10 0.05 0.02 0.01
Total non-current liabilities + 0.20 0.23 0.10 0.12 0.02 0.48 0.22
Total liabilities 0.34 0.41 0.19 0.22 0.07 0.50 0.23
Total stockholders' equity + 1.13 1.03 0.46 0.49 0.54 -0.21 -0.12
Common shares outstanding 447 274 208 176 170 166 166
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Total cash and short-term investments + 0.65 0.74 0.66 0.53 0.50 0.59 0.43 0.47 0.30 0.39 0.39 0.41 0.47 0.55 0.45 0.52 0.59 0.52 0.58 0.63 0.21 0.26 0.00 0.00 0.07
Accounts receivable, net 0.01 0.02 0.02 0.02 0.05 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01
Other current assets 0.04 0.04 0.03 0.04 0.04 0.07 0.04 0.05 0.04 0.04 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.01 0.01 0.00
Total current assets 0.71 0.81 0.71 0.59 0.58 0.71 0.47 0.52 0.34 0.44 0.41 0.43 0.49 0.57 0.48 0.55 0.62 0.53 0.60 0.65 0.22 0.27 0.07
Total non-current assets + 0.63 0.66 0.69 0.72 0.72 0.73 0.25 0.25 0.21 0.22 0.22 0.24 0.14 0.13 0.13 0.13 0.11 0.08 0.06 0.05 0.05 0.03 -0.07
Total assets 1.34 1.47 1.40 1.30 1.31 1.45 0.73 0.78 0.56 0.65 0.63 0.67 0.63 0.70 0.61 0.67 0.73 0.61 0.66 0.70 0.27 0.30
Total current liabilities + 0.13 0.15 0.16 0.16 0.14 0.19 0.11 0.09 0.07 0.09 0.09 0.11 0.09 0.10 0.08 0.10 0.09 0.05 0.04 0.03 0.03 0.02
Total non-current liabilities + 0.19 0.20 0.20 0.22 0.23 0.23 0.09 0.11 0.08 0.10 0.10 0.08 0.11 0.12 0.14 0.14 0.16 0.02 0.02 0.03 0.48 0.48
Total liabilities 0.31 0.34 0.35 0.38 0.37 0.41 0.20 0.19 0.16 0.19 0.19 0.20 0.20 0.22 0.22 0.23 0.24 0.07 0.06 0.06 0.50 0.50
Total stockholders' equity + 1.02 1.13 1.05 0.92 0.93 1.03 0.52 0.58 0.40 0.46 0.44 0.47 0.43 0.49 0.39 0.44 0.49 0.54 0.60 0.64 -0.23 -0.21 0.08
Common shares outstanding 529 527 447 417 403 336 283 242 236 233 214 201 192 186 173 172 171 169 169 168 168 167 169 168 168
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19
Operating cash flow + -0.37 -0.36 -0.29 -0.08 -0.16 -0.05 -0.06
Cash flow from investing + -0.02 0.26 -0.01 0.19 -0.27 -0.01 0.00
Cash flow from financing + 0.52 0.30 0.14 0.15 0.46 0.25 0.12
Change in cash 0.13 0.21 -0.16 0.26 0.03 0.19 0.06
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20
Operating cash flow + -0.08 -0.05 -0.12 -0.08 -0.13 -0.12 -0.06 -0.08 -0.10 -0.07 -0.07 -0.07 -0.07 -0.04 -0.05 -0.06 0.08 -0.06 -0.03 -0.03 -0.03 0.01 -0.02 -0.02 -0.02
Cash flow from investing + 0.00 0.00 0.00 -0.01 -0.01 0.28 0.00 0.00 -0.01 0.00 0.00 0.00 -0.01 -0.01 0.05 0.00 0.14 -0.05 -0.19 -0.01 -0.02 0.00 0.00 0.00 0.00
Cash flow from financing + 0.00 0.13 0.25 0.10 0.04 0.01 0.02 0.26 0.01 0.08 0.05 0.00 0.00 0.15 0.00 0.00 0.00 0.00 -0.01 0.46 0.00 0.01 0.23 0.00 0.01
Change in cash -0.08 0.08 0.13 0.02 -0.10 0.17 -0.05 0.18 -0.10 0.00 -0.02 -0.07 -0.08 0.09 0.00 -0.05 0.22 -0.11 -0.24 0.42 -0.05 0.01 0.21 -0.02 -0.01
4 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Operating Cashflow

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Other Non Operating Income

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Net Income

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Ebitda

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Ebit

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Net Income From Continuing Operations

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Income Tax Expense

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Income Before Tax

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Depreciation And Amortization

1Y 2Y 5Y Max
8 days ago

RECURSION PHARMACEUTICALS, INC. (RXRX) - Interest Expense

1Y 2Y 5Y Max
8 days ago